Ann Surg
- BRADA LJH, Schouten TJ, Daamen LA, Seelen LWF, et al
Evaluation of Short- and Long-Term Outcomes After Resection in Patients with
Locally Advanced versus (Borderline) Resectable Pancreatic Cancer.
Ann Surg. 2024 Apr 1. doi: 10.1097/SLA.0000000000006289.
BMC Surg
- HOU TY, Lin YH, Liu YW, Liu YY, et al
The impact of preoperative nutritional status on postoperative outcomes: an
insight from Geriatric Nutritional Risk Index in elderly pancreaticoduodenectomy
patients.
BMC Surg. 2024;24:100.
Br J Surg
- UNDERWOOD PW, Cloyd JM
Comment on: Predictive value of baseline serum carbohydrate antigen 19-9 level on
treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and
borderline resectable pancreatic cancer in two randomized trials.
Br J Surg. 2024;111:znae085.
Dig Dis Sci
- JABER F, Alsakarneh S, Alsharaeh T, Salahat AJ, et al
Adverse Events and Device Failures Associated with Pancreatic Stents: A
Comprehensive Analysis Using the FDA's MAUDE Database.
Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08396.
Gut
-
Correction: Identification of c-FLIPL and c-FLIPS as critical regulators of death
receptor-induced apoptosis in pancreatic cancer cells.
Gut. 2024;73:e8.
- WANG YC, Mao XT, Sun C, Wang YH, et al
Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects
against pancreatitis in mice.
Gut. 2024 Mar 29:gutjnl-2023-330788. doi: 10.1136/gutjnl-2023-330788.
Pancreatology
- JOSHI K, Espino DM, Shepherd DE, Mahmoodi N, et al
Pancreatic anastomosis training models: Current status and future directions.
Pancreatology. 2024 Apr 1:S1424-3903(24)00081-4. doi: 10.1016/j.pan.2024.
- TANG CY, Yang SH, Li CP, Su YY, et al
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus
5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.
Pancreatology. 2024 Mar 25:S1424-3903(24)00076-0. doi: 10.1016/j.pan.2024.
- PARK Y, Han YB, Kim J, Kang M, et al
Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens
to predict post-surgical recurrence: A prospective cohort study.
Pancreatology. 2024 Mar 23:S1424-3903(24)00074-7. doi: 10.1016/j.pan.2024.
- FAN M, Ma Y, Deng G, Si H, et al
A real-world analysis of second-line treatment option, Gemcitabine plus Anlotinib
and anti-PD1, in advanced pancreatic cancer.
Pancreatology. 2024 Mar 25:S1424-3903(24)00078-4. doi: 10.1016/j.pan.2024.
PLoS One
- ZHANG C, Lin F, Guo DF, Wang QL, et al
Assessing the causal link between liver function and acute pancreatitis: A
Mendelian randomisation study.
PLoS One. 2024;19:e0300890.
- MEHRA T, Lupatsch JE, Kossler T, Dedes K, et al
Olaparib not cost-effective as maintenance therapy for platinum-sensitive,
BRCA1/2 germline-mutated metastatic pancreatic cancer.
PLoS One. 2024;19:e0301271.
Scand J Gastroenterol
- GJELA M, Askeland A, Mellergaard M, Drewes AM, et al
Intra-pancreatic fat deposition and its relation to obesity: a magnetic resonance
imaging study.
Scand J Gastroenterol. 2024 Apr 1:1-7. doi: 10.1080/00365521.2024.2333365.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016